1. Search Result
Search Result
Results for "

MAF

" in MedChemExpress (MCE) Product Catalog:

12

Inhibitors & Agonists

1

Peptides

1

Inhibitory Antibodies

8

Recombinant Proteins

5

Antibodies

6

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99136
    Anti-Mouse IFN gamma Antibody (H22)
    1 Publications Verification

    IFNAR Infection Inflammation/Immunology
    Anti-Mouse IFN gamma Antibody (H22) is an anti-mouse IFN gamma IgG antibody inhibitor derived from host Armenian Hamster. Anti-Mouse IFN gamma Antibody (H22) abrogates specific binding of I25II-rIFN-γ to macrophages. Anti-Mouse IFN gamma Antibody (H22) inhibits macrophage-activating factor (MAF) (ID50 = 56 ng). Anti-Mouse IFN gamma Antibody (H22) inhibits IFN-gamma dependent antiviral activity (ID50 = 2 ng). Anti-Mouse IFN gamma Antibody (H22) neutralizes IFNγ in mice. Anti-Mouse IFN gamma Antibody (H22) can be used for the researches of inflammation and infection, such as arthritis .
    Anti-Mouse IFN gamma Antibody (H22)
  • HY-119271

    SDS-1-021

    c-Myc Apoptosis Cancer
    CMLD010509 (SDS-1-021) is a highly specific inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MYC, MDM2, CCND1, MAF, and MCL-1. CMLD010509 (SDS-1-021) shows an IC50 below 10 nM for most MM cell lines and induces apoptosis. CMLD010509 (SDS-1-021) is a potent and selective translation inhibitor through an eIF4E phosphorylation-independent mechanism .
    CMLD010509
  • HY-W339331

    NNI-0001

    Insecticide Calcium Channel Reactive Oxygen Species (ROS) Apoptosis Infection Metabolic Disease
    Flubendiamide (NNI-0001) is an orally active phthalic diamide insecticide that acts by targeting insect ryanodine receptors (RyRs), causing insect muscle dysfunction, paralysis and death. Flubendiamide disrupts molting, metamorphosis and reproductive processes, induces oxidative stress by increasing the levels of ROS/RNS, MDA and 8OHdG and decreasing the levels of SOD, CAT and GST, activates the CncC/Maf apoptosis pathway, impairs calcium homeostasis, promotes adipogenesis, increases triglyceride accumulation, and upregulates the expression of regulatory factors for adipocyte differentiation and adipogenesis .
    Flubendiamide
  • HY-RS07956

    Small Interfering RNA (siRNA) Others

    MAF Human Pre-designed siRNA Set A contains three designed siRNAs for MAF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MAF Human Pre-designed siRNA Set A
    MAF Human Pre-designed siRNA Set A
  • HY-RS07957

    Small Interfering RNA (siRNA) Others

    MAF1 Human Pre-designed siRNA Set A contains three designed siRNAs for MAF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MAF1 Human Pre-designed siRNA Set A
    MAF1 Human Pre-designed siRNA Set A
  • HY-RS27194

    Small Interfering RNA (siRNA) Others
    Mmd Rat Pre-designed siRNA Set A contains three designed siRNAs for Mmd gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
    Mmd Rat Pre-designed siRNA Set A
    Mmd Rat Pre-designed siRNA Set A
  • HY-P11601

    Biochemical Assay Reagents Cancer
    MAF-10L is a membrane-disrupting agent, a cationic amphipathic Mastoparan AF derivative with enhanced α-helicity. MAF-10L preferentially interacts with DOPS lipids in cancer cell membranes, disrupting cancer cell membranes to trigger membrane leakage. MAF-10L can be used for the research of cancer .
    MAF-10L
  • HY-119271A

    (-)-SDS-1-021

    c-Myc Apoptosis Cancer
    (-)-CMLD010509 ((-)-SDS-1-021) is an isomer of CMLD010509 (SDS-1-021) (HY-119271). CMLD010509 (SDS-1-021) is a highly specific inhibitor of the oncogenic translation program supporting multiple myeloma (MM)-including key oncoproteins such as MYC, MDM2, CCND1, MAF, and MCL-1. CMLD010509 (SDS-1-021) shows an IC50 below 10 nM for most MM cell lines and induces apoptosis. CMLD010509 (SDS-1-021) is a potent and selective translation inhibitor through an eIF4E phosphorylation-independent mechanism .
    (-)-CMLD010509
  • HY-RS17799

    Small Interfering RNA (siRNA) Others

    Maf Mouse Pre-designed siRNA Set A contains three designed siRNAs for Maf gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Maf Mouse Pre-designed siRNA Set A
    Maf Mouse Pre-designed siRNA Set A
  • HY-RS24267

    Small Interfering RNA (siRNA) Others

    Maf Rat Pre-designed siRNA Set A contains three designed siRNAs for Maf gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Maf Rat Pre-designed siRNA Set A
    Maf Rat Pre-designed siRNA Set A
  • HY-185661

    CCR Cancer
    IBS007125 is a c-Maf inhibitor. IBS007125 does not alter the protein level or post-translational modification of c-Maf. IBS007125 inhibits some target genes of c-Maf (such as ITGB7 and CCR1). IBS007125 exerts anticancer effects on multiple myeloma expressing c-Maf. IBS007125 can be used for the research of multiple myeloma .
    IBS007125
  • HY-174585

    mRNA Metabolic Disease
    Human MAFA mRNA encodes the human MAF bZIP transcription factor A (MAFA) protein, a transcription factor that regulates pancreatic beta cell-specific expression of the insulin gene.
    Human MAFA mRNA

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: